# Ascendin Fund

> Ascendin Fund is a VC fund in Beijing backing Health Care, Biotechnology and Medical. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Beijing, China
- Total investments: 4
- Last investment: Apr 2026
- Lead investor: 25%
- Last updated: Aug 2026
- Website: http://www.ascendinfund.com

Ascendin Fund is a VC fund in Beijing focused on Health Care and Biotechnology. Ascendin Fund focuses on pharmaceutical, intelligent & real estate fields.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 75% |
| Biotechnology | 3 | 75% |
| Medical | 1 | 25% |
| Genetics | 1 | 25% |
| Biopharma | 1 | 25% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 50% |
| Angel | 1 | 25% |
| Series B | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Baijuyi Commercial | Baijuyi Commercial focuses on providing homeowners with full-process, one-stop property asset management services, covering every stage from property acquisition and leasing to daily operations, maintenance, tenant management, and eventual resale or investment optimization. By integrating professional expertise, market insights, and tailoredsolutions, it aims to maximize property value, enhance operational efficiency, and deliver a seamless, worry-free experience for property owners. | $290.5K | Angel | Apr 01, 2026 |  |
| Polaris Biology | Polaris Biology is a medical technology company specializing in the development and clinical application of cell-level precision diagnostic technology, is dedicated to exploring and studying individual and dynamic changes in tumors at the cellular level, and using this information to support clinical tumor diagnosis and treatment. | $9.9M | Series B | Jun 24, 2020 |  |
| CureGenetics | Cure Genetics is a biotechnology company developing cutting-edge applications of technologies in innovative medicines and molecular diagnostics for the next-generation treatment of cancers and genetic diseases. | $17M | Series A | Aug 06, 2018 |  |
| Tekeluo Biotech | Tekeluo Biotech is a Healthcare company. | $4.5M | Series A | Aug 01, 2018 |  |

4 of 4 investments shown.

## Co-investors
- [Baidu Ventures](https://shizune.co/investors/profile/baidu-ventures) — VC Fund, 1 deal together
- [Delian Capital](https://shizune.co/investors/profile/delian-capital) — VC Fund, 1 deal together
- [Emerging Technology Partners](https://shizune.co/investors/profile/emerging-technology-partners) — VC Fund, 1 deal together
- JMCR Partners — VC Fund, 1 deal together
- [Kaitai Capital](https://shizune.co/investors/profile/kaitai-capital) — VC Fund, 1 deal together
- [5Y Capital](https://shizune.co/investors/profile/morningsidevc) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Ascendin Fund invest in?

Ascendin Fund invests primarily in Health Care, Biotechnology and Medical startups, most often at Series A and Angel stage. Most of the 4 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Ascendin Fund last invest?

The most recent investment recorded for Ascendin Fund closed in Apr 2026. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co